Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5-Reference-Cited by-同舟云学术

Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5

Published:2010-12 Issue:24 Volume:56 Page:2021-2030
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Zhang Manling,Takimoto Eiki,Hsu Steven,Lee Dong I.,Nagayama Takahiro,Danner Thomas,Koitabashi Norimichi,Barth Andreas S.,Bedja Djahida,Gabrielson Kathleen L.,Wang Yibin,Kass David A.

Funder

National Institutes of Health–National Heart, Lung, and Blood Institute

Fondation Leducq

American Heart Association

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics;Tsai;Pharmacol Ther,2009

2. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta;Das;J Biol Chem,2008

3. Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy due to pressure-overload;Nagayama;J Am Coll Cardiol,2009

4. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy;Takimoto;Nat Med,2005

5. Phos-phodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity;Fisher;Circulation,2005

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials;Current Atherosclerosis Reports;2024-04-02

2. Pde5 Inhibition Reduced Blood Pressure and Alleviated Target Organ Damage in Chronic Intermittent Hypoxia;Journal of Cardiovascular Pharmacology;2023-11-23

3. Modulation of the nitric oxide/cGMP pathway in cardiac contraction and relaxation: Potential role in heart failure treatment;Pharmacological Research;2023-10

4. Shunxin decoction improves diastolic function in rats with heart failure with preserved ejection fraction induced by abdominal aorta constriction through cyclic guanosine monophosphate-dependent protein kinase Signaling Pathway;J TRADIT CHIN MED;2022

5. Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure;Nature Reviews Cardiology;2022-09-01